Aceclidine

CAS No. 827-61-2

Aceclidine( Glaucostat | 3-Acetoxyquinuclidine | 3-quinuclidinyl acetate | 1-azabicyclo[2.2.2]octan-3-yl acetate | Quinuclidin-3-yl acetate )

Catalog No. M27183 CAS No. 827-61-2

Aceclidine is an agent that is used for treating glaucoma by reducing intraocular pressure.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 28 In Stock
500MG 48 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aceclidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Aceclidine is an agent that is used for treating glaucoma by reducing intraocular pressure.
  • Description
    Aceclidine is an agent that is used for treating glaucoma by reducing intraocular pressure.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Glaucostat | 3-Acetoxyquinuclidine | 3-quinuclidinyl acetate | 1-azabicyclo[2.2.2]octan-3-yl acetate | Quinuclidin-3-yl acetate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Dengue Fever virus| Ebola virus| HCV| HIV-1| Rift Valley virus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    827-61-2
  • Formula Weight
    169.224
  • Molecular Formula
    C9H15NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (590.95 mM)
  • SMILES
    CC(=O)OC1CN2CCC1CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Aman MJ, et al. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Res. 2009 Sep;83(3):245-51.
molnova catalog
related products
  • JAMM protein inhibit...

    JAMM protein inhibitor 2?is an inhibitor of JAMM protease and can be used for anticancer studies. The IC50s are 10 μM, 46 μM, and 89 μM for thrombin, Rpn11, and MMP2, respectively.

  • Osteogenic Growth Pe...

    Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations. Osteogenic growth peptide OGP is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury.

  • Opigolix

    Opigolix, a Gonadotropin-releasing hormone receptor antagonist, treats hormone-dependent conditions by inhibiting the actions of gonadotropin-releasing hormone (GnRH).